ASCEND BY NTHRYS
Research Abroad Products

Molecular Diagnostics Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Next-Generation Rare Disease Phenotype Matching Engine
A proprietary algorithm platform that matches patient phenotypes and genotypes to rare disease databases, enabling differential diagnosis acceleration. The platform monetizes through API licensing to EHR systems, research institutions, and diagnostic laboratories globally.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Scalable Laboratory Information System for Rare Disease Testing
An integrated LIMS platform purpose-built for rare disease molecular testing workflows, specimen tracking, and regulatory compliance reporting. The software generates recurring revenue from mid-to-large diagnostic labs while reducing turnaround times and manual errors.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Carrier Screening and Risk Stratification Commercial Platform
A direct-to-consumer and B2B genomic testing product that identifies carriers of rare genetic disorders with personalized risk reporting. Revenue streams include test kit sales, downstream clinical follow-up services, and partnerships with genetic counseling networks.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Rare Disease Clinical Trial Patient Recruitment Tool Suite
A B2B software platform that connects patients with rare disease diagnoses to relevant clinical trials through automated matching and outreach workflows. Pharmaceutical and biotech companies pay licensing fees while generating cost savings through accelerated patient enrollment.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Portable Rare Disease Molecular Diagnostics Hardware System
A compact, automated molecular diagnostic device that performs rare disease testing in point-of-care settings without requiring centralized laboratory infrastructure. The hardware generates initial sales margins while consumable cartridges create recurring revenue from distributed healthcare networks.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Rare Disease Genomic Data Repository and Analytics Marketplace
A secure cloud platform aggregating anonymized genomic and phenotypic data from rare disease patients to enable research and improve diagnostic algorithms. Revenue derives from data licensing to pharmaceutical firms, research institutions, and diagnostic companies seeking competitive insights.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Real-time Tumor Mutation Profiling SaaS Platform
Cloud-based diagnostic platform that processes next-generation sequencing data to identify actionable tumor mutations within 48 hours for clinical reporting. Enables laboratories to offer rapid companion diagnostic services, commanding premium reimbursement rates and expanding market share in precision oncology.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
AI-Powered Biomarker Discovery and Validation Tool
Machine learning software that accelerates identification of novel predictive biomarkers from multi-omics datasets for drug development partnerships. Generates licensing revenue streams and establishes pharmaceutical collaborations worth millions in upfront and milestone payments.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
Liquid Biopsy ctDNA Analysis Commercial Service
Laboratory-developed test service detecting circulating tumor DNA variants for early cancer detection and treatment monitoring with minimal invasiveness. Creates recurring patient testing revenue while reducing infrastructure costs through centralized processing and automated quality control.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
Immunotherapy Companion Diagnostic Panel Kit
Certified diagnostic kit measuring PD-L1 expression, tumor mutational burden, and microsatellite instability to predict checkpoint inhibitor response. Captures substantial in vitro diagnostic market share by becoming standard-of-care testing for leading immunotherapy drugs.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
Integrated Laboratory Information Management System
CLIA-compliant software platform managing sample tracking, result reporting, and regulatory compliance for molecular oncology diagnostics laboratories. Reduces operational costs by 30-40 percent while improving throughput and enabling seamless electronic health record integration for higher adoption.
Molecular Oncology Companion Diagnostic Dev Click to view more details →
Pharmacogenomics-Guided Cancer Treatment Recommendation Engine
Automated platform that matches patient tumor genetics with optimal chemotherapy regimens and dosing strategies based on metabolizer phenotype data. Improves treatment efficacy outcomes while reducing adverse events, driving adoption by oncology centers and generating subscription-based licensing fees.
Molecular Oncology Companion Diagnostic Dev Click to view more details →